Recent progresses in chemotherapy for pediatric brain tumors

Abstract

Recently molecular classifications of pediatric brain tumors, especially medulloblastoma, ependymoma and diffuse intrinsic pontine gliomas (DIPG), have progressed. Various molecular targeting agents have also been developed. We need to knownot only standard therapies but also various therapeutic options according to the novel information. Here we reviewed recent progresses in chemotherapy in medulloblastoma, ependymoma and DIPG, including molecular subtyping.